Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Melanoma

  Free Subscription


Articles published in Nat Med

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    July 2019
  1. RIBAS A, Lawrence D, Atkinson V, Agarwal S, et al
    Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma.
    Nat Med. 2019 Jul 2. pii: 10.1038/s41591-019-0535.
    PubMed     Text format     Abstract available


    June 2019
  2. RIBAS A, Lawrence D, Atkinson V, Agarwal S, et al
    Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma.
    Nat Med. 2019 Jun 6. pii: 10.1038/s41591-019-0476.
    PubMed     Text format     Abstract available


  3. ASCIERTO PA, Ferrucci PF, Fisher R, Del Vecchio M, et al
    Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma.
    Nat Med. 2019 Jun 6. pii: 10.1038/s41591-019-0448.
    PubMed     Text format     Abstract available


  4. ROZEMAN EA, Blank CU
    Combining checkpoint inhibition and targeted therapy in melanoma.
    Nat Med. 2019 Jun 6. pii: 10.1038/s41591-019-0482.
    PubMed     Text format    


  5. SULLIVAN RJ, Hamid O, Gonzalez R, Infante JR, et al
    Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients.
    Nat Med. 2019 Jun 6. pii: 10.1038/s41591-019-0474.
    PubMed     Text format     Abstract available


    May 2019
  6. ZAPPASODI R, Sirard C, Li Y, Budhu S, et al
    Rational design of anti-GITR-based combination immunotherapy.
    Nat Med. 2019;25:759-766.
    PubMed     Text format     Abstract available


    March 2019
  7. NEWMAN S, Fan L, Pribnow A, Silkov A, et al
    Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas.
    Nat Med. 2019 Mar 4. pii: 10.1038/s41591-019-0373.
    PubMed     Text format     Abstract available


  8. LONG GV
    Making a difference to many.
    Nat Med. 2019;25:356.
    PubMed     Text format    


  9. TURAJLIC S
    Standing on the shoulders of giants.
    Nat Med. 2019;25:357.
    PubMed     Text format    


    February 2019
  10. HUANG AC, Orlowski RJ, Xu X, Mick R, et al
    A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.
    Nat Med. 2019 Feb 25. pii: 10.1038/s41591-019-0357.
    PubMed     Text format     Abstract available


    December 2018
  11. TRUCCO LD, Mundra PA, Hogan K, Garcia-Martinez P, et al
    Publisher Correction: Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma.
    Nat Med. 2018 Dec 18. pii: 10.1038/s41591-018-0325.
    PubMed     Text format     Abstract available


  12. TRUCCO LD, Mundra PA, Hogan K, Garcia-Martinez P, et al
    Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma.
    Nat Med. 2018 Dec 3. pii: 10.1038/s41591-018-0265.
    PubMed     Text format     Abstract available


    November 2018
  13. ROBERT C
    Is earlier better for melanoma checkpoint blockade?
    Nat Med. 2018;24:1645-1648.
    PubMed     Text format     Abstract available


    October 2018
  14. CEREZO M, Guemiri R, Druillennec S, Girault I, et al
    Translational control of tumor immune escape via the eIF4F-STAT1-PD-L1 axis in melanoma.
    Nat Med. 2018 Oct 29. pii: 10.1038/s41591-018-0217.
    PubMed     Text format     Abstract available


  15. AMARIA RN, Reddy SM, Tawbi HA, Davies MA, et al
    Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
    Nat Med. 2018 Oct 25. pii: 10.1038/s41591-018-0252.
    PubMed     Text format     Abstract available


  16. AMARIA RN, Reddy SM, Tawbi HA, Davies MA, et al
    Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
    Nat Med. 2018 Oct 25. pii: 10.1038/s41591-018-0251.
    PubMed     Text format     Abstract available


  17. AUSLANDER N, Zhang G, Lee JS, Frederick DT, et al
    Publisher Correction: Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma.
    Nat Med. 2018 Oct 17. pii: 10.1038/s41591-018-0247.
    PubMed     Text format     Abstract available


  18. BLANK CU, Rozeman EA, Fanchi LF, Sikorska K, et al
    Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma.
    Nat Med. 2018 Oct 8. pii: 10.1038/s41591-018-0198.
    PubMed     Text format     Abstract available


  19. AMARIA RN, Reddy SM, Tawbi HA, Davies MA, et al
    Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
    Nat Med. 2018 Oct 8. pii: 10.1038/s41591-018-0197.
    PubMed     Text format     Abstract available


    August 2018
  20. AUSLANDER N, Zhang G, Lee JS, Frederick DT, et al
    Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma.
    Nat Med. 2018 Aug 20. pii: 10.1038/s41591-018-0157.
    PubMed     Text format     Abstract available


    January 2018
  21. BOSHUIZEN J, Koopman LA, Krijgsman O, Shahrabi A, et al
    Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.
    Nat Med. 2018 Jan 15. pii: nm.4472. doi: 10.1038/nm.4472.
    PubMed     Text format     Abstract available


    October 2017
  22. MURGAI M, Ju W, Eason M, Kline J, et al
    KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis.
    Nat Med. 2017;23:1176-1190.
    PubMed     Text format     Abstract available


    August 2017
  23. XUE Y, Martelotto L, Baslan T, Vides A, et al
    An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer.
    Nat Med. 2017;23:929-937.
    PubMed     Text format     Abstract available


    July 2017
  24. MAYORCA-GUILIANI AE, Madsen CD, Cox TR, Horton ER, et al
    ISDoT: in situ decellularization of tissues for high-resolution imaging and proteomic analysis of native extracellular matrix.
    Nat Med. 2017;23:890-898.
    PubMed     Text format     Abstract available


    December 2016
  25. PEINADO H, Alec kovic M, Lavotshkin S, Matei I, et al
    Corrigendum: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.
    Nat Med. 2016;22:1502.
    PubMed     Text format    


    October 2016
  26. LINNEMANN C, van Buuren MM, Bies L, Verdegaal EM, et al
    Corrigendum: High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.
    Nat Med. 2016;22:1192.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: